Anxiety is Linked to Gut Health

Could probiotics help treat it?

Translate to Spanish or other 102 languages!

Anxiety is linked to decreased diversity in gut bacteria. Could probiotics help treat it? Image for illustration purposes
Anxiety is linked to decreased diversity in gut bacteria. Could probiotics help treat it? Image for illustration purposes
- Advertisement -
  • Experts are interested in how the gut microbiota may influence mental health conditions like anxiety.
  • One narrative review suggests that people with anxiety can experience decreased microbial diversity and fewer short-chain fatty acid-producing bacteria.
  • The finding also suggests that using probiotics could help to improve anxiety symptoms.

The gut microbiota refers to the microorganisms that live in the gut.

A narrative review recently published in the journal Nutrients sought to look at data on changes in the gut microbiota in people with anxiety disorders and on how probiotics may help improve anxiety symptoms.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/anxiety-is-linked-to-gut-health-could-probiotics-help-treat-it?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-03-18&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

$281 Million Unlocked to Bridge the Gap in Rural Medical Access

AUSTIN - Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will receive $281 million in federal funding for the second year of Rural Texas Strong, a five-year initiative to improve rural healthcare throughout the state.

Skin Myths Dermatologists Want You to Stop Believing Immediately

Have you ever wondered what a dermatologist's top skincare recommendations are

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.
- Advertisement -